Clinical Characteristics and Treatment Outcomes of Patients with Pulmonary Tuberculosis at a Private General Hospital.
10.4046/trd.2003.55.2.154
- Author:
Won Jung KOH
1
;
O Jung KWON
;
Cheol Hong KIM
;
Young Mee AHN
;
Seong Yong LIM
;
Jong Wook YUN
;
Jung Hye HWANG
;
Gee Young SUH
;
Man Pyo CHUNG
;
Hojoong KIM
;
Jung Wook LEE
;
Jin Sook SUH
Author Information
1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. ojkwon@smc.samsung.co.kr
- Publication Type:Original Article
- Keywords:
Pulmonary tuberculosis;
Private sector;
Private Practice;
Diagnosis;
Treatment outcome;
Korea
- MeSH:
Diagnosis;
Ethambutol;
Hospitals, General*;
Humans;
Isoniazid;
Korea;
Private Practice;
Private Sector;
Public Health;
Pyrazinamide;
Rifampin;
Sputum;
Treatment Outcome;
Tuberculosis;
Tuberculosis, Pulmonary*
- From:Tuberculosis and Respiratory Diseases
2003;55(2):154-164
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Until the early 1990's in Korea, treatment outcomes of patients with pulmonary tuberculosis in the private sector were reported to be inferior to those of the public health center under the National Tuberculosis Programme. The purpose of this study was to analyze the clinical characteristics and the treatment efficacy of the patients with pulmonary tuberculosis recently diagnosed at a private general hospital. MATERIALS and METHODS: The study included all pulmonary tuberculosis patients diagnosed at Samsung Medical Center and notified to the public health center from August 2000 to January 2001. RESULTS: Of the 232 patients included in the study during a 6-month period, 188 were (81.0%) initial treatment cases and 44 (19.0%) were re-treatment cases. Eighty-three (35.8%) patients had smear-positive sputa, and 27 (11.6%) had smear-negative, culture-positive sputa. Initial sputum examinations were not performed in 47 (20.3%) patients. A six-month, short-course treatment using isoniazid, rifampin, ethambutol and pyrazinamide was prescribed for 31.4% of the patients under the initial treatment. The success rate (cured plus treatment completed) of the initial treatment for the smear-positive patients was 69.1%. Eleven (13.3%) of the 83 patients with smear-positive pulmonary tuberculosis discontinued their treatment without notice. CONCLUSIONS: To improve the treatment efficacy and decrease the default rates of the patients with pulmonary tuberculosis in the private sector, further efforts are required in line with the Korean Academy of Tuberculosis and Respiratory Disease Treatment Guidelines and in the implementation of an appropriate model of public-private mix for tuberculosis control in Korea.
